Imricor Medical Systems, Inc. (IMR.AX)

0,4800 -0,0400 (-7,69%) Börsenschluss: 04:10PM AEST

Imricor Medical Systems, Inc.

400 Gateway Boulevard
Burnsville, MN 55337
United States
952 818 8400
https://www.imricor.com

Sektor(en): Healthcare
Branche: Medical Devices
Vollzeitmitarbeiter: 

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Steve Wedan	President, CEO & Executive Chairman	723,53k	N/A	1969
Mr. Jonathon Gut	CFO & VP of Finance	403,67k	N/A	N/A
Mr. Gregg Stenzel	Chief Operating Officer	490,24k	N/A	N/A
Mr. Greg Englehardt	Senior Director of Sales	N/A	N/A	N/A
Mr. Nick Twohy	Vice President of Marketing & Business Development	N/A	N/A	N/A
Mr. Kobe Lizheng	Company Secretary & Local Agent	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in AUD.

Beschreibung

Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States. The company's principal product includes the Advantage-MR EP Recorder/Stimulator system, an EP recording system and cardiac stimulator. Its products also include Vision-MR Ablation Catheter, which is used as an indication for treating type I atrial flutter; and Vision-MR Dispersive Electrode that is used to minimize eddy currents induced on the conductive pads during MR scanning. It also performs contract research, as well as licenses its intellectual property for use in implantable devices. Imricor Medical Systems, Inc. was incorporated in 2006 and is headquartered in Burnsville, Minnesota.

Corporate Governance

Imricor Medical Systems, Inc.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.